143 related articles for article (PubMed ID: 2473808)
21. Autoimmune thrombocytopenic purpura (AITP) and acquired thrombasthenia due to autoantibodies to GP IIb-IIIa in a patient with an unusual platelet membrane glycoprotein composition.
Macchi L; Nurden P; Marit G; Bihour C; Clofent-Sanchez G; Combrié R; Nurden AT
Am J Hematol; 1998 Feb; 57(2):164-75. PubMed ID: 9462551
[TBL] [Abstract][Full Text] [Related]
22. In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function.
Michelson AD; Barnard MR; Hechtman HB; MacGregor H; Connolly RJ; Loscalzo J; Valeri CR
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11877-82. PubMed ID: 8876231
[TBL] [Abstract][Full Text] [Related]
23. Effects of leukocyte-derived cathepsin G on platelet membrane glycoprotein Ib-IX and IIb-IIIa complexes: a comparison with thrombin.
Molino M; Di Lallo M; Martelli N; de Gaetano G; Cerletti C
Blood; 1993 Oct; 82(8):2442-51. PubMed ID: 8400294
[TBL] [Abstract][Full Text] [Related]
24. A defect of platelet aggregation associated with an abnormal distribution of glycoprotein IIb-IIIa complexes within the platelet: the cause of a lifelong bleeding disorder.
Hardisty R; Pidard D; Cox A; Nokes T; Legrand C; Bouillot C; Pannocchia A; Heilmann E; Hourdillé P; Bellucci S
Blood; 1992 Aug; 80(3):696-708. PubMed ID: 1638023
[TBL] [Abstract][Full Text] [Related]
25. How vitronectin binds to activated glycoprotein IIb-IIIa complex and its function in platelet aggregation.
Mohri H; Ohkubo T
Am J Clin Pathol; 1991 Nov; 96(5):605-9. PubMed ID: 1719797
[TBL] [Abstract][Full Text] [Related]
26. Factor XIIIa binding to activated platelets is mediated through activation of glycoprotein IIb-IIIa.
Cox AD; Devine DV
Blood; 1994 Feb; 83(4):1006-16. PubMed ID: 7906563
[TBL] [Abstract][Full Text] [Related]
27. Complement proteins C5b-9 initiate secretion of platelet storage granules without increased binding of fibrinogen or von Willebrand factor to newly expressed cell surface GPIIb-IIIa.
Ando B; Wiedmer T; Hamilton KK; Sims PJ
J Biol Chem; 1988 Aug; 263(24):11907-14. PubMed ID: 3261296
[TBL] [Abstract][Full Text] [Related]
28. Monoclonal antibodies to platelet glycoproteins Ib and IIb/IIIa inhibit adhesion of platelets to purified solid-phase von Willebrand factor.
Danton MC; Zaleski A; Nichols WL; Olson JD
J Lab Clin Med; 1994 Aug; 124(2):274-82. PubMed ID: 8051492
[TBL] [Abstract][Full Text] [Related]
29. Role of glycoprotein IIb-IIIa (alpha IIb beta 3-integrin) in stimulation of secretion from platelet granules.
Naimushin YA; Mazurov AV
Biochemistry (Mosc); 2003 Feb; 68(2):209-16. PubMed ID: 12693968
[TBL] [Abstract][Full Text] [Related]
30. The effects of nitric oxide (NO) on platelet membrane receptor expression during activation with human alpha-thrombin.
Keh D; Gerlach M; Kürer I; Seiler S; Kerner T; Falke KJ; Gerlach H
Blood Coagul Fibrinolysis; 1996 Sep; 7(6):615-24. PubMed ID: 8899151
[TBL] [Abstract][Full Text] [Related]
31. Surface expression of major membrane glycoproteins on resting and TRAP-activated neonatal platelets.
Simák J; Holada K; Janota J; Stranák Z
Pediatr Res; 1999 Oct; 46(4):445-9. PubMed ID: 10509366
[TBL] [Abstract][Full Text] [Related]
32. Characterization of an anti-thrombospondin monoclonal antibody (P8) that inhibits human blood platelet functions. Normal binding of P8 to thrombin-activated Glanzmann thrombasthenic platelets.
Boukerche H; McGregor JL
Eur J Biochem; 1988 Jan; 171(1-2):383-92. PubMed ID: 3338471
[TBL] [Abstract][Full Text] [Related]
33. A monoclonal antibody to a membrane glycoprotein binds only to activated platelets.
McEver RP; Martin MN
J Biol Chem; 1984 Aug; 259(15):9799-804. PubMed ID: 6746667
[TBL] [Abstract][Full Text] [Related]
34. Identification of platelet glycoprotein IIb/IIIa as the major binding site for released platelet-von Willebrand factor.
Parker RI; Gralnick HR
Blood; 1986 Sep; 68(3):732-6. PubMed ID: 3017478
[TBL] [Abstract][Full Text] [Related]
35. Function of glycoprotein Ib alpha in platelet activation induced by alpha-thrombin.
De Marco L; Mazzucato M; Masotti A; Fenton JW; Ruggeri ZM
J Biol Chem; 1991 Dec; 266(35):23776-83. PubMed ID: 1748654
[TBL] [Abstract][Full Text] [Related]
36. Significant reduction in the binding of a monoclonal antibody (LYP 18) directed against the IIb/IIIa glycoprotein complex to platelets of patients having undergone extracorporeal circulation.
Dechavanne M; Ffrench M; Pages J; Ffrench P; Boukerche H; Bryon PA; McGregor JL
Thromb Haemost; 1987 Feb; 57(1):106-9. PubMed ID: 2438795
[TBL] [Abstract][Full Text] [Related]
37. The Arg-Gly-Asp (RGD) recognition site of platelet glycoprotein IIb-IIIa on nonactivated platelets is accessible to high-affinity macromolecules.
Tomiyama Y; Tsubakio T; Piotrowicz RS; Kurata Y; Loftus JC; Kunicki TJ
Blood; 1992 May; 79(9):2303-12. PubMed ID: 1373972
[TBL] [Abstract][Full Text] [Related]
38. Downregulation of the platelet surface glycoprotein Ib-IX complex in whole blood stimulated by thrombin, adenosine diphosphate, or an in vivo wound.
Michelson AD; Ellis PA; Barnard MR; Matic GB; Viles AF; Kestin AS
Blood; 1991 Feb; 77(4):770-9. PubMed ID: 1704263
[TBL] [Abstract][Full Text] [Related]
39. Effect of aspirin on platelet-von Willebrand factor surface expression on thrombin and ADP-stimulated platelets.
Parker RI; Gralnick HR
Blood; 1989 Nov; 74(6):2016-21. PubMed ID: 2529923
[TBL] [Abstract][Full Text] [Related]
40. Detection of platelet activation with monoclonal antibodies and flow cytometry. Changes during platelet storage.
Fijnheer R; Modderman PW; Veldman H; Ouwehand WH; Nieuwenhuis HK; Roos D; de Korte D
Transfusion; 1990 Jan; 30(1):20-5. PubMed ID: 1688666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]